P
ProHub
English 简体中文 繁體中文
Hard Comparison Product Decision Packaging Strategy

DrugGen

#Healthcare (Pharma Ops) #Pharmaceuticals #Healthcare
ProHub Comment

This is a candidate-led comparison case requiring structured analysis of a packaging innovation decision for an oncology drug. The case tests the candidate's ability to evaluate financial and non-financial factors, conduct brainstorming around operational implications, and synthesize insights into a clear recommendation with risk mitigation. The 15-20 minute timeframe demands efficient prioritization and on-the-fly idea generation.

Estimated Time 15 minutes
Difficulty Hard
Source PeterK
50 / 100
DrugGen is a U.S.-based drug company. Given trends toward patient compliance and eco-friendliness, they are considering changing the packaging of an oncology drug. After assessing a lot of options (plastic bottles, parenteral containers, blister packaging, pens, etc.) through a set of strict requirements (like cold storage, enhanced protection against moisture, oxygen and other gases, unit-dose control, counterfeit protection, child-resistant properties, and cost efficiency) DrugGen identified a potential new cold chain tech packaging. The CEO has hired you to suggest if they should go for it.

Clarifying Information

  1. New packaging comprises a low temperature container
  2. Patients take 4 pills of this drug and then 2 additional generic steroids per day
  3. Five other pharma companies offer similar oncology drugs
  4. DrugGen distributes this drug globally
  5. DrugGen captures 1-2% of the global market, or 20k units of drug per year
  6. The drug’s price is $4k for monthly supply (120 pills)
  7. The patient population for this cancer type isn’t expanding
  8. No specific goals provided